期刊文献+

心力衰竭患者血栓前状态临床研究 被引量:3

Changes of Markers of Prethrombotic State and Their Clinical Significance with Heart Failure
下载PDF
导出
摘要 目的研究慢性心力衰竭(CHF)时血栓前状态标志物的变化,探讨其临床意义。方法测定52例CHF患者及38例健康体检者血浆中组织型纤溶酶原激活剂(t-PA)、纤溶酶原激活剂抑制物-1(PAI-1)、纤维蛋白原(Fg)、血浆凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、内皮素-1(ET-1)、平均血小板体积(MPV)水平。结果不同程度CHF患者的血浆PAI-1、Fg、ET-1水平均较正常对照组明显增高。结论CHF存在血栓前状态,并与CHF的严重程度有关。 Objective To investigate changes of markers of prethrombotic state(PTS) with heart failure and to explore their clinical significances. Methods Plasma levels of t - PA.PAI - 1 ,Fg,PT,APTT.ET - 1 .MPV were measured in 52 patients with heart failure and in 38 normal controls. Results Compared with the healthy control group, patients with heart failure had significant increase of plasma PAl - 1 .Fg and ET - 1 level. Conclusions PTS is present in heart failure, especially in those with more severe Nyha class.
出处 《医学研究杂志》 2006年第8期57-58,共2页 Journal of Medical Research
关键词 心力衰竭 血栓前状态 Heart failure Prethrombotic state
  • 相关文献

参考文献6

  • 1Jafri SM, et al. Effects of warfarin on makers of hypereoagulability in patients with heart failure. Am Heart J, 1997, 134:27 -36.
  • 2陆再英.慢性心力衰竭[A].见:叶任高主编.内科学:第5版[C].北京:人民卫生出版社,2001.159-169.
  • 3王志坚,赵水平.心力衰竭患者纤溶参数变化及药物干预效果的评价[J].中国循环杂志,2002,17(1):38-40. 被引量:13
  • 4Hubocka Z, et al. Is mild essential hypertension without obvious organ complications and risk factors associated with increased levels of circulating markers of endothelial dysfunction? Effect of ACE inhibitor therapy. Vnitr Lek, 2002,48:718 - 723.
  • 5Giannessi D, et al. The role of endothelins and their receptors in heart failure. Pharmacol Res,2001,43 : 111 - 126.
  • 6De Mant MP, et al. Inflammation thrombosis and atherosclerosis results of the Glostrup study. J Thromb Haemost, 2003,1:950- 957.

二级参考文献7

  • 1[1]Catherin L,David E,Newby,et al.Fibrinolytic actions of intra-arterial angiotensin Ⅱ and bradykinin in vivo in man.Cardiov Res,2000,47:707-714.
  • 2[2]Douglas E,Vaughan jean L,Gean L,et al.Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction.Circulation, 1997,96:442-447.
  • 3[3]Chritopher R,Gibbs M,Andrew D,et al.Abnormalities of hemorheological endothelial and pulatelet in patients with chronic heart failure in sinus rhythm,Effects of angiotensin-converting enzyme inhibit and β-blocker therapy.Circulation,2001,103:1746-1751.
  • 4[4]Nicholas ER,Goodfield MB,David E,et al.Effect of acute angiotensin Ⅱ type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patient with heart failure.Circulation,1999,99:2983-2985.
  • 5[5]Douglas E,Vaughan S,Lazos,et al.Angiotensin Ⅱ regulates the rexpression of plasminogen activator inhibitor-1 in cultured endothelial cell.J Clin Invest,1995,95:995-1001.
  • 6[6]Ridker P,Cynthia L,Gaboury,et al.Stimulation of plasminogen activator inhinbitor in vivo by the fusion of angiotensin Ⅱ,Evidence of a potential interaction between the rennin-angiotensin system and fibrinolytic function.Circulation,1993,87:1969-1973.
  • 7[7]Nancy J,Brown MD,James V,et al.Bradykinin stimulates tissue plasminogen activator release from human forearm vasculatue through B2 recepto-dependent,NO synthase-independnt and cyclooxygenase-independent pathway.Circulation, 2000,102:2190-2196.

共引文献14

同被引文献33

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部